Methylation profiling

Dataset Information

0

Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma


ABSTRACT: The implication of epigenetic alterations in the pathogenesis of melanoma is increasingly recognized. Here we performed genome-wide DNA methylation analysis of primary cutaneous melanoma and benign melanocytic naevus interrogating 14,495 genes using beadchip technology. This first genome-wide view of promoter methylation in primary cutaneous melanoma revealed an array of recurrent DNA methylation alterations with potential diagnostic applications. Among 106 frequently hypermethylated genes there were many novel methylation targets and tumor suppressor genes. Highly recurrent methylation of the HOXA9, MAPK13, CDH11, PLEKHG6, PPP1R3C and CLDN11genes was established. Promoter methylation of MAPK13, encoding p38?, was present in 67% of primary and 85% of metastatic melanomas. Restoration of MAPK13 expression in melanoma cells exhibiting epigenetic silencing of this gene reduced proliferation, indicative of tumor suppressive functions. This study demonstrates that DNA methylation alterations are widespread in melanoma and suggests that epigenetic silencing of MAPK13 contributes to melanoma progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE45266 | GEO | 2013/04/24

SECONDARY ACCESSION(S): PRJNA193430

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-04-24 | E-GEOD-45266 | biostudies-arrayexpress
2013-12-20 | GSE53516 | GEO
2013-12-20 | E-GEOD-53516 | biostudies-arrayexpress
2021-09-21 | GSE178416 | GEO
2022-05-12 | GSE202750 | GEO
2013-07-01 | E-GEOD-45354 | biostudies-arrayexpress
2013-09-19 | E-GEOD-44661 | biostudies-arrayexpress
2015-11-01 | E-MTAB-3481 | biostudies-arrayexpress
2014-05-28 | E-GEOD-57971 | biostudies-arrayexpress
2012-12-31 | E-GEOD-31879 | biostudies-arrayexpress